Cartilage reconstruction in head and neck surgery: comparison of resorbable polymer scaffolds for tissue engineering of human septal cartilage.

New cell culture techniques raise the possibility of creating cartilage in vitro with the help of tissue engineering. In this study, we compared two resorbable nonwoven cell scaffolds, a polyglycolic acid/poly-L-lactic acid (PGA/PLLA) (90/10) copolymer (Ethisorb) and pure PLLA (V 7-2), with different degradation characteristics in their aptitude for cartilage reconstruction. Chondrocytes were isolated enzymatically from human septal cartilage. The single cells were resuspended in agarose and transferred into the polymer scaffolds to create mechanical stability and retain the chondrocyte-specific phenotype. The cell-polymer constructs were then kept in perfusion culture for 1 week prior to subcutaneous transplantation into thymusaplastic nude mice. After 6, 12, and 24 weeks, the specimens were explanted and analyzed histochemically on the presence of collagen (azan staining), proteoglycans (Alcian blue staining), and calcification areas (von Kossa staining). Furthermore, different collagen types (collagen type I, which is found in most tissues, but not in hyaline cartilage matrix; and collagen type II, which is cartilage specific) were differentiated immunohistochemically by the indirect immunoperoxidase technique. Vascular ingrowth was investigated by a factor VIII antibody, which is a endothelial marker. Quantification of several matrix components was performed using the software Photoshop. Significant differences were found between both nonwoven structures concerning matrix synthesis and matrix quality as well as vascular ingrowth. Ethisorb, with a degradation time of approximately 3 weeks in vitro, showed no significant differences from normal human septal cartilage in the amount of collagen types I and II 24 weeks after transplantation. Thin fibrous tissue layers containing blood vessels encapsulated the transplants. V 7-2 constructs, which did not show strong signs of degradation even 24 weeks after transplantation, contained remarkably smaller amounts of cartilage-specific matrix components. At the same time, there was vascular ingrowth even in central parts of the transplants. In conclusion, polymer scaffolds with a short degradation time are suitable materials for the development of cartilage matrix products, while longer stability seems to inhibit matrix synthesis. Thus, in vitro engineering of human cartilage can result in a cartilage-like tissue when appropriate nonwovens are used. Therefore, this method could be the ideal cartilage replacement method without the risk of infection and with the possibility of reconstructing large defects with different configurations.

[1]  T. Inglis,et al.  Cialit preserved cartilage: failure to guarantee sterility. , 1988, British Journal of Plastic Surgery.

[2]  M. Karnovsky,et al.  THE HISTOCHEMICAL DEMONSTRATION OF MONOAMINE OXIDASE ACTIVITY BY COUPLED PEROXIDATIC OXIDATION , 1965, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[3]  J. Vacanti,et al.  Formation of urothelial structures in vivo from dissociated cells attached to biodegradable polymer scaffolds in vitro. , 1992, The Journal of urology.

[4]  J. Vacanti,et al.  Synthetic Polymers Seeded with Chondrocytes Provide a Template for New Cartilage Formation , 1991, Plastic and reconstructive surgery.

[5]  J. Bujía Die Züchtung von autologem Knorpelgewebe für die rekonstruktive Chirurgie: Möglichkeiten und Grenzen , 1995 .

[6]  M A Moses,et al.  Identification of an inhibitor of neovascularization from cartilage. , 1990, Science.

[7]  M. Mittelstaedt Influence of centrifugal force on angular velocity estimation. , 1995, Acta oto-laryngologica. Supplementum.

[8]  R. Langer,et al.  Isolation and characterization of an inhibitor of neovascularization from scapular chondrocytes , 1992, The Journal of cell biology.

[9]  J. Vacanti,et al.  Tissue engineering : Frontiers in biotechnology , 1993 .

[10]  C. Hammer,et al.  Culture and cryopreservation of chondrocytes from human cartilage: relevance for cartilage allografting in otolaryngology. , 1992, ORL; journal for oto-rhino-laryngology and its related specialties.

[11]  E. Kastenbauer,et al.  Resorbable polyesters in cartilage engineering: affinity and biocompatibility of polymer fiber structures to chondrocytes. , 1996, Journal of biomedical materials research.

[12]  Kastenbauer Er [Preservation and application possibilities of allogenic (homologous) transplants in the ear, nose and throat region]. , 1983 .

[13]  L. Gürtler,et al.  Human immunodeficiency virus cannot productively infect freshly cultured human cartilage cells. , 1993, ORL; journal for oto-rhino-laryngology and its related specialties.

[14]  M. Karnovsky,et al.  CYTOCHEMICAL DEMONSTRATION OF PEROXIDASE ACTIVITY WITH 3-AMINO-9-ETHYLCARBAZOLE , 1965, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[15]  W W Minuth,et al.  Artificial Tissues in Perfusion Culture , 1997, The International journal of artificial organs.

[16]  A. Sun,et al.  Xenografts of rat islets into diabetic mice. An evaluation of new smaller capsules. , 1992, Transplantation.

[17]  R. Dermietzel,et al.  Construction of an apparatus for perfusion cell cultures which enables in vitro experiments under organotypic conditions. , 1992, European journal of cell biology.

[18]  J. Vacanti,et al.  Temporomandibular joint disc replacement made by tissue-engineered growth of cartilage. , 1994, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[19]  E. Kastenbauer,et al.  Detection of class II antigens on human nasal cartilage. , 1990, American journal of otolaryngology.

[20]  J. Čejka Enzyme immunoassay for factor VIII-related antigen. , 1982, Clinical chemistry.

[21]  M. Sittinger,et al.  Antigen presenting cell function of class II positive human nasal chondrocytes. , 1994, Acta oto-laryngologica.

[22]  G. Zalzal Rib Cartilage Grafts for the Treatment of Posterior Glottic and Subglottic Stenosis in Children , 1988, The Annals of otology, rhinology, and laryngology.

[23]  E. Kastenbauer,et al.  Engineering of cartilage tissue using bioresorbable polymer fleeces and perfusion culture. , 1995, Acta oto-laryngologica.

[24]  J. Ingerslev,et al.  The multimeric structure of plasma F VIII:RAg studied by electroelution and immunoperoxidase detection. , 1986, Thrombosis research.

[25]  W W Minuth,et al.  Tissue engineering and autologous transplant formation: practical approaches with resorbable biomaterials and new cell culture techniques. , 1996, Biomaterials.

[26]  V. Muzykantov,et al.  Distribution of type I, III, IV and V collagen in normal and atherosclerotic human arterial wall: immunomorphological characteristics. , 1985, Collagen and related research.

[27]  A M Sun,et al.  In vitro and in vivo evaluation of microencapsulated porcine islets. , 1992, ASAIO journal.

[28]  H. Wolf,et al.  Zur Übertragbarkeit von HIV-Infektionen durch allogene Transplantate , 1987 .

[29]  S. Gay,et al.  The extracellular matrix is an integrated unit: ultrastructural localization of collagen types I, III, IV, V, VI, fibronectin, and laminin in human term placenta. , 1986, Collagen and related research.

[30]  W W Minuth,et al.  Engineering of cartilage tissue using bioresorbable polymer carriers in perfusion culture. , 1994, Biomaterials.

[31]  J. Vacanti,et al.  Heterotopic hepatocyte transplantation: assessing the impact of hepatotrophic stimulation. , 1994, Transplantation proceedings.

[32]  Gordana Vunjak-Novakovic,et al.  Tissue Engineering of Cartilage , 1999 .

[33]  C. Ohlsson,et al.  Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. , 1994, The New England journal of medicine.

[34]  E. Thonar,et al.  Chemical stabilization of cartilage matrix. , 1994, Journal of Surgical Research.

[35]  R Langer,et al.  Design of nasoseptal cartilage replacements synthesized from biodegradable polymers and chondrocytes. , 1994, Biomaterials.